FDA Clears Clarius Prostate AI for Ultrasound Use
Clarius Mobile Health has launched Clarius Prostate AI, the first FDA-cleared, AI-powered tool for real-time prostate volume and PSA density measurement. Designed to speed up urologic diagnostics, it reduces manual processes and supports earlier prostate cancer detection. Available via Clarius scanners, it streamlines exams with a simple tap on a smartphone or tablet.